Keywords
How to Cite
Abstract
The increasing popularity of the concept of liquid biopsy, which involves the definition of circulating tumor cells and circulating nucleic acids in the blood can significantly improve long-term results of treatment for gastric cancer due to the high sensitivity of techniques. It needs further study in relation to gastric cancer, the search for universal markers and methods.References
Карпин А. Д., Старинский В. В., Петрова Г. В. Злокачественные новообразования в России в 2014 году. - Москва: Коллектив авторов МНИОИ им. П. А. Герцена. - 2016. - 250 с.
Ashworth T. A case of cancer in which cells similar to those in the tumours were seen in the blood after death // Aust Med J. -1 869. - Vol. 14. - P. 146-149.
Beeharry M. K., Liu WT., Yan M., Zhu ZG. New blood markers detection technology: A leap in the diagnosis of gastric cancer // World J Gastroenterol. - 2016. - Vol. 22, № 3. - P. 1202-1212.
Chen X., Ba X., Ma L. et al. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases // Cell Res. -2008. - Vol. 18, № 10. - P. 997-1006.
Chen X.Q., Bonnefoi H., Pelte M.F. et al. Telomerase RNA as a detection marker in the serum of breast cancer patients // Clin Cancer Res. - 2000. - Vol. 6, № 10. - P. 3823-3826.
Cohen S.J., Punt C.J., Iannotti N. et al. Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer // J Clin oncol. - 2008. - Vol. 26, № 19. - P. 3213-3221.
Coumans F.A., van Dalum G., Beck M., Terstappen L.W. Filtration parameters influencing circulating tumor cell enrichment from whole blood // PLos one. - 2013. - Vol. 8, №4.
Cristofanilli M., Budd G.T., Ellis M.J. et al. Circulating tumor cells, disease progression, and survival in metastatic breast cancer // N Engl J Med. - 2004. - Vol. 351, № 8. - P. 781-791.
Danila D.C., Heller G., Gignac G.A. et al. Circulating tumor cell number and prognosis in progressive castration-resistant prostate cancer // Clin Cancer Res. - 2007. - Vol. 13, № 23. - P. 7053-7058.
Dasf F., Martfnez-Rodes P., March J.A. et al. Real-time quantification of human telomerase reverse transcriptase mRNA in the plasma of patients with prostate cancer // Ann N Y Acad sci. - 2006. - Vol. 1075. - P. 204-210.
Diaz L.A., Williams R.T., Wu J. et al. The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancers // Nature. - 2012. - Vol. 486, № 7404. - P. 537-540.
Gorur A., Balci Fidanci s., Dogruer Unal N. et al. Determination of plasma microRNA for early detection of gastric cancer // Mol Biol Rep. - 2013. - Vol. 40, № 3. - P. 2091-2096.
Hiraiwa K., Takeuchi H., Hasegawa H. et al. Clinical significance of circulating tumor cells in blood from patients with gastrointestinal cancers // Ann surg oncol. - 2008. - Vol. 15, № 11. - P. 3092-3100.
Ikeguchi M., Kaibara N. Detection of circulating cancer cells after a gastrectomy for gastric cancer // surg Today. - 2005. - Vol. 35, № 6. - P. 436-441.
Ishigami S., Natsugoe s., Hokita s. et al. Clinical importance of preoperative carcinoembryonic antigen and carbohydrate antigen 19-9 levels in gastric cancer // J Clin Gastroenterol. - 2001. - Vol. 32, № 1. - P. 41-44.
Ismailova G., Laget s., Paterlini-Br chot P. Detection of Circulating Tumor cells by ISET and their molecular characterization for use as liquid biopsy // J Clin Med Kaz. - 2015. - Vol. 1, № 35. - P. 15-20.
Jacques F., Soerjomataram I., Dikshit R. et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012 // Int. J. Cancer. - 2015. - Vol. 136, № 5. - P. 359-386.
Konishi H., Ichikawa D., Komatsu s. et al. Detection of gastric cancer-associated microRNAs on microRNA microarray comparing pre- and post-operative plasma // Br J Cancer. - 2012. - Vol. 106, № 4. - P. 740-747.
Kopreski Ms., Benko F.A., Kwak L.W., Gocke CD. Detection of tumor messenger RNA in the serum of patients with malignant melanoma // Clin Cancer Res. - 1999. - Vol. 5, № 5. - P. 1961-1965.
Leon S.A., shapiro B., sklaroff D. M., Yaros M.J. Free DNA in the serum of cancer patients and the effect of therapy // Cancer Res. - 1977. - Vol. 37, № 3 - P. 646-650.
Marrinucci D., Bethel K., Bruce R.H. et al. Case study of the morphologic variation of circulating tumor cells // Hum Pathol. - 2007. - Vol. 38, № 3. - P. 514-519.
Matsusaka S., Chin K., Ogura M. et al. Circulating tumor cells as a surrogate marker for determining response to chemotherapy in patients with advanced gastric cancer // Cancer Sci. - 2010. - Vol. 101, № 4. - P 10671071.
Mimori K., Fukagawa T., Kosaka Y. et al. A large-scale study of MT1-MMP as a marker for isolated tumor cells in peripheral blood and bone marrow in gastric cancer cases // Ann Surg Oncol. - 2008. - Vol. 15, № 10. -P. 2934-2942.
Misale S., Yaeger R., Hobor S. et al. Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancer // Nature. - 2012. - Vol. 486, № 7404. - P. 532-536.
Mitchell P.S., Parkin R.K., Kroh E.M. et al. Circulating mi-croRNAs as stable blood-based markers for cancer detection // Proc Natl Acad Sci USA. - 2008. - Vol. 105, № 30. - P. 10513-10518.
Miyazono F., Natsugoe S., Takao S. et al. Surgical maneuvers enhance molecular detection of circulating tumor cells during gastric cancer surgery // Ann Surg. - 2001. - Vol. 233, № 2. - P. 189-194.
Munz M., Baeuerle PA., Gires O. The emerging role of EpCAM in cancer and stem cell signaling // Cancer Res. - 2009. - Vol. 69, № 14. - P. 5627-5629.
Nishida S., Kitamura K., Ichikawa D. et al. Molecular detection of disseminated cancer cells in the peripheral blood of patients with gastric cancer // Anticancer Res. - 2000. - Vol. 20, № 3B. - P. 2155-2159.
Liu H., Zhu L., Liu B. et al. Genome-wide microRNA profiles identify miR-378 as a serum biomarker for early detection of gastric cancer // Cancer Lett. - 2012. - Vol. 316, № 2. - P. 196-203.
Liu R., Zhang C., Hu Z. et al. A five-microRNA signature identified from genome-wide serum microRNA expression profiling serves as a fingerprint for gastric cancer diagnosis // Eur J Cancer. - 2011. - Vol. 47, № 5. -P. 784-791.
Pituch-Noworolska A., Kolodziejczyk P., Kulig J. et al. Circulating tumour cells and survival of patients with gastric cancer // Anticancer Res. - 2007. - Vol. 27, № 1B. - P. 635-640.
Riethdorf S., Fritsche H., Müller V. et al. Detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancer: a validation study of the Cell-Search system // Clin Cancer Res. - 2007. - Vol. 13, № 3. - P. 920-928.
Schwarzenbach H., Alix-Panabières C., Müller I. et al. Cell-free tumor DNA in blood plasma as a marker for circulating tumor cells in prostate cancer // Clin Cancer Res. - 2009. - Vol. 15, № 3. - P. 1032-1038.
Sequist L.V., Nagrath S., Toner M. et al. The CTC-Chip: An exciting new tool to detect circulating tumor cells in lung cancer patients // J Thorac Oncol. - 2009. - Vol. 4, № 3. - P. 281-283.
Silva J.M., Rodriguez R., Garcia J.M. et al. Detection of epithelial tumour RNA in the plasma of colon cancer patients is associated with advanced stages and circulating tumour cells // Gut. - 2002. - Vol. 50, № 4. -P. 530-534.
Sorenson G.D., Pribish D.M., Valone FH. et al. Soluble normal and mutated DNA sequences from single-copy genes in human blood // Cancer Epidemiol Biomarkers Prev. - 1994. - Vol. 3, № 1. - P. 67-71.
Stroun M., Maurice P., Vasioukhin V. et al. The origin and mechanism of circulating DNA // Ann N Y Acad Sci. -2000. - Vol. 906. - P. 161-168
Thompson EW., Haviv I. The social aspects of EMT-MET plasticity // Nat Med. - 2011. - Vol. 17, № 9. -P. 1048-1049.
Tsai K.W., Liao Y.L., Wu C.W. et al. Aberrant expression of miR-196a in gastric cancers and correlation with recurrence // Genes Chromosomes Cancer. - 2012. - Vol. 51, № 4. - P. 394-401.
Tsujiura M., Ichikawa D., Konishi H. et al. Liquid biopsy of gastric cancer patients: Circulating tumor cells and cell-free nucleic acids // World J Gastroenterol. - 2014. -Vol. 20, № 12. - P. 3265-3286.
Uen Y.H., Lin S.R., Wu C.H. et al. Clinical significance of MUC1 and c-Met RT-PCR detection of circulating tumor cells in patients with gastric carcinoma // Clin Chim Acta. - 2006. - Vol. 367, № 1-2. - P. 55-61.
van der Gun B.T., Melchers L.J., Ruiters M.H. et al. EpCAM in carcinogenesis: the good, the bad or the ugly // Carcinogenesis. - 2010. - Vol. 31, № 11. - P. 1913-1921.
Vasioukhin V., Anker P., Maurice P. et al. Point mutations of the N-ras gene in the blood plasma DNA of patients with myelodysplastic syndrome or acute myelogenous leukaemia // Br J Haematol. - 1994. - Vol. 86, № 4. - P. 774-779.
Vona G., Sabile A., Louha M. et al. Isolation by size of epithelial tumor cells: a new method for the immuno-morphological and molecular characterization of circulatingtumor cells // Am J Pathol. - 2000. - Vol. 156, № 1. - P. 57-63.
Wang B., Zhang Q. The expression and clinical significance of circulating microRNA-21 in serum of five solid tumors // J Cancer Res Clin Oncol. - 2012. - Vol. 138, № 10. - P. 1659-1666.
Wang M., Gu H., Wang S. et al. Circulating miR-17-5p and miR-20a: molecular markers for gastric cancer // Mol Med Rep. - 2012. - Vol. 5, № 6. - P. 1514-1520.
Wenqi D., Li W., Shanshan C. et al. EpCAM is over-expressed in gastric cancer and its downregulation suppresses proliferation of gastric cancer // J Cancer Res Clin Oncol. - 2009. - Vol. 135, № 9. - P. 1277-1285.
Wu C.H., Lin S.R., Hsieh J.S. et al. Molecular detection of disseminated tumor cells in the peripheral blood of patients with gastric cancer: evaluation of their prognostic significance // Dis Markers. - 2006. - Vol. 22, № 3. - P. 103-109.
Wu C.H., Lin S.R., Yu F.J. et al. Development of a high-throughput membranearray method for molecular diagnosis of circulating tumor cells in patients with gastric cancers // Int J Cancer. - 2006. - Vol. 119, № 2. - P. 373-379.
Zheng S., Lin H., Liu J.Q. et al. Membrane microfilter device for selective capture, electrolysis and genomic analysis of human circulating tumor cells // J Chromatogr A. - 2007. - Vol. 1162, № 2. - P. 154-161.
All the Copyright statements for authors are present in the standart Publishing Agreement (Public Offer) to Publish an Article in an Academic Periodical 'Problems in oncology' ...